Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling Pathway
Frontiers in Pharmacology [2018]
Chen Donglai, Zhang Fuquan, Wang Jinhui, He Hua, Duan Shanzhou, Zhu Rongying, Chen Chang, Yin Lichen, Chen Yongbing
